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Arrhythmogenic right ventricular cardiomyopathy (ARVD/C) is a genetically heterogeneous disease characterized
by progressive degeneration of the right ventricular myocardium and increased risk of sudden death. Here, we
report on a genome scan in one Italian family in which the disease appeared unlinked to any of the six different
ARVD loci reported so far; we identify a mutation (S299R) in exon 7 of desmoplakin (DSP), which modifies a
putative phosphorylation site in the N-terminal domain binding plakoglobin. It is interesting that a nonsense DSP
mutation was reported elsewhere in the literature, inherited as a recessive trait and causing a biventricular dilative
cardiomyopathy associated with palmoplantar keratoderma and woolly hairs. Therefore, different DSP mutations
might produce different clinical phenotypes, with different modes of inheritance.
Arrhythmogenic right ventricular cardiomyopathy
(ARVD/C) is a progressive disease characterized by de-
generation of right ventricular myocardium, followed by
fibrous-fatty replacement (Thiene et al. 1988). Myocar-
dial degeneration may extend to left ventricle (Gallo et
al. 1992; Pinamonti et al. 1992; Basso et al. 1996) and,
less frequently, to interventricular septum (Basso et al.
1996). ARVD/C is usually clinically present with ar-
rhythmias of right ventricular origin, ranging from iso-
lated premature ventricular beats to sustained ventric-
ular tachycardia or to ventricular fibrillation leading to
sudden death (Marcus et al. 1982). ARVD/C is the most
common cause of sudden cardiac death in juveniles in
northeast Italy (Corrado et al. 1990).
Seven dominant forms of ARVD/C were identified so
far: ARVD1 (14q24.3) (Rampazzo et al. 1994 [MIM
107970]), ARVD2 (1q42) (Rampazzo et al. 1995 [MIM
600996]), ARVD3 (14q11-q12) (Severini et al. 1996
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[MIM 602086]), ARVD4 (2q32) (Rampazzo et al. 1997
[MIM 602087]), ARVD5 (3p23) (Ahmad et al. 1998),
ARVD6 (10p12-p14) (Li et al. 2000 [MIM 602087]),
and ARVD7 (10q22) (Melberg et al. 1999). Among
them, only the gene involved in ARVD2 has been iden-
tified to date (Tiso et al. 2001). The only known auto-
somal recessive form of ARVD/C is associated with
palmoplantar keratoderma and peculiar woolly hairs
(Naxos syndrome [MIM 601214]), caused by a homo-
zygous 2-nucleotide deletion in the plakoglobin (JUP)
gene, the product of which is a key component of des-
mosomes and adherens junctions (McKoy et al. 2000).
Here, we report on the identification of a causative
mutation in one family, in which disease was inherited
unlinked to any of the different ARVD/C loci reported
so far.
The index case of the present study (subject III,9) was
a young male who, at 18 years and during physical ef-
fort, experienced a cardiac arrest due to ventricular fib-
rillation. By thorough clinical investigation, he was di-
agnosed as affected with ARVD/C. His family included
26 members in four generations. All family members
gave informed consent to be evaluated and to give blood
samples for DNA study. The protocol (Nava el al. 2000)
included: 12-lead electrocardiogram (ECG), signal-av-
eraged ECG, 24 hHolter ECG, 2D-echocardiogram.Ad-
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(Minor)Major Minor Major Minor
II,4       Sustained VT 2/4
II,6       Sustained VT 2/3
III,4        0/4
III,9       VF, PVCs 2/3
III,10       PVCs 0/5
III,12        0/4
III,13       PVCs 0/5
IV,3       VF 1/2
IV,4       PVCs 0/4
IV,6       PVCs 1/3
IV,9        1/2
NOTE.—A plus sign () indicates presence, and a minus sign () indicates absence.
a VFpventricular fibrillation.
Figure 1 a, Twelve-lead ECG of patient III,9 (index case); presence of low voltages of QRS, QRS duration in V1-V21V5-V6, negative T
wave from V1 to V5. b, 2D-echocardiogram of the same patient (apical four-chamber view). Right ventricle (left of panel) is severely dilated,
with trabecular disarrangement; left ventricle also appears to be affected.
ditional procedures (right and left ventricular angiog-
raphy with coronary arteriography) were performed
only on strict clinical indication. Diagnosis was made
according to McKenna et al. (1994): affection status is
established when two major criteria, one major criterion
plus two minor criteria, or four minor criteria are ful-
filled. Criteria involve genetic, structural, histological,
electrocardiographic, and arrhythmological aspects. Af-
ter clinical evaluation, 11 individuals were identified as
being affected with ARVD/C (table 1) on the basis of
ECG, echocardiographic, and/or angiographic findings;
ventricular arrhythmias with left bundle branch block
morphology; and/or presence of late potentials at signal
averaged ECG (McKenna et al. 1994; Nava et al. 2000).
Typical ECG and echocardiographical images are shown
in fig. 1. Three patients (II,4; II,6; and III,9) manifested
a severe form of the disease, three (III,13; IV,3; and IV,6)
a moderate form, and the remaining ones displayed a
mild form. In this last group of patients, repolarization
abnormalities were present at ECG in all cases, accom-
panied, in two subjects, by isolated PVCs. Ventricular
arrhythmias occurred isolated or in couplets/triplets in
five patients (III,9; III,10; III,13; IV,4; and IV,6), whereas,
in two, they progressed to sustained ventricular tachy-
cardia (II,4 and II,6). In all individuals, ventricular ar-
rhythmias were characterized by left bundle branch
block morphology, with left axis deviation in six cases,
and with right axis deviation in one. Two patients ex-
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Table 2
Two-Point LOD Scores for Different Recombination Fractions for
6p24 Markers in the Family Reported in Figure 2
LOD SCORE AT v p
vmax ZmaxMARKER .00 .01 .05 .10 .20 .30 .40
D6S1574 1.60 1.69 2.15 2.13 1.75 1.18 .52 .05 2.15
D6S1640 3.95 3.88 3.58 3.20 2.38 1.49 .57 .00 3.95
D6S309 4.32 4.25 3.95 3.57 2.74 1.82 .83 .00 4.32
D6S470 4.27 4.20 3.91 3.53 2.71 1.80 .82 .00 4.27
D6S1721 3.64 3.58 3.32 2.99 2.28 1.50 .66 .00 3.64
D6S259 4.25 2.28 .82 .23 .20 .27 .17 .30 .27
NOTE.—LOD scores were calculated by assuming 0.95 penetrance as
restrictive criterion.
Figure 2 Family tree, showing haplotypes for chromosome 6p24 markers (ordered from telomere to centromere). Filled squares or circles
indicate affected individuals; shaded squares or circles indicate individuals still under investigation. The shared disease-associated haplotype is
boxed. The critical region, identified by informative recombination events (indicated by X), occurred in individuals III,12, II,4, and III,13.
perienced ventricular fibrillation that, in one case, led to
sudden death (IV, 3). During follow-up, which lasted,
depending on the patient, for 2–17 years (average 10
years), three individuals (II,4; II,6; and III,9) showed a
progression of the disease with left ventricular involve-
ment. In these patients, right ventricle appeared severely
dilated at 2D-echo (mean value of right ventricular and
diastolic ), and ratio betweenvolumep 130 10ml/m2
right and left ventricular volumes was higher than 1.7.
The left ventricular kinetic alterations were localized in
the posterior wall in two cases and in the anterior wall
and apex in the third case. Ejection fraction appeared
more severely depressed (332) in the right ventricle
than in the left (455).
Two patients died suddenly (II,1 and IV,3) at ages 65
years and 15 years, respectively, and another (II,6) died
because of heart failure at age 68 years. No affected
subjects in the family showed phenotypic peculiarities
such as woolly hairs, skin alterations, or additional ge-
netic diseases.
Genetic investigation revealed no linkage of the dis-
ease running in the family with any DNA marker of
known ARVD loci. For this reason, a 5-cM genome-
wide scan was performed to map the disease locus. A
genome scan was performed using 700 microsatellite
markers (Applied Biosystems Prism Linkage Mapping
Set Version 2.5). All family members were additionally
genotyped for D6S1640, obtained from MWG Biotech.
In addition, for assessing marker order and intermarker
distances on chromosome 6, data from the Human Ge-
nome Browser (April 2002 release) was used.
Significantly positive linkage was detected for
D6S1640, D6S309, D6S470, and D6S1721 (Z pmax
at for marker D6S309), mapped to 6p244.32 vp 0
(table 2). All patients shared a common haplotype (fig.
2). Since the novel locus (6p24) described in this paper
is the eighth reported so far for dominant ARVDs, it
should be named ARVD8. Penetrance, estimated in the
former two generations of the family, was ∼50%.
ARVD8 is probably infrequent, at least in northeast It-
aly: among 16 families in which we have firmly estab-
lished linkage with ARVD/C loci, the family reported
here is the only one in which the disease was linked to
6p.
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Figure 3 All investigated patients showed the presence of an additional band, visible on top of the electrophoretic pattern (arrow), in
PCR amplicons of desmoplakin exon 7, once subjected to SSCP analysis. DNA sequencing of such amplicons revealed a CrG transition (codon
299, from AGC to AGG, resulting in a SerrArg substitution), which is present only in the affected members of the family. The lower band,
detected by SSCP analysis in some individuals, corresponds to an additional polymorphism (I305F) identified in the same exon.
Figure 4 Alignment of the Z region from N-terminal domains of desmosomal members of the plakin family; protein names, GenBank
accession numbers, and amino acid termini are reported on the right. A gray background indicates phylogenetic conservation of residues. Serine
or threonine residues corresponding to putative PKC phosphorylation sites are shown in white characters on a black background. On the
bottom, secondary structure (SS) consensus is shown (c p coil; h p helical) and its profile probability is reported (9, up to 100%; 8, up to
90%, and so on). The Ser residue, mutated in patients, is marked by an asterisk. This residue is central to a surface and acidic coiled region
surrounded by two helices. This predicted PKC phosphorylation site is conserved in all phylogenetically related sequences: DPI (desmoplakin),
BPAG1 (bullous pemphigoid antigen 1), PLEC1 (plectin), PPL (periplakin). HspHomo sapiens; MmpMus musculus; RnpRattus norvegicus;
and CgpCricetulus griseus.
Recombinations detected in subjects III,12, II,4, and
III,13 enabled us to define a critical region between
D6S1574 and D6S259, spanning ∼9 Mb, which was
confirmed by multipoint analysis (data not shown). Gene
encoding desmoplakin (DSP), located between D6S1640
and D6S309, appeared as a candidate, since a homo-
zygous DSP nonsense mutation was reported to cause,
in an Ecuadorian family, a biventricular dilative car-
diomyopathy associated with keratoderma and woolly
hairs (Carvajal-Huerta 1998; Norgett et al. 2000), now
referred as “Carvajal syndrome” (MIM 605676).
Mutation screening was performed by direct sequenc-
ing. Flanking intronic sequences of each DSP exon were
determined by comparing cDNA sequence (GenBank ac-
cession number M77830) with genomic sequence, avail-
able from public databases. PCR primers flanking
each exon of the human DSP gene were designed by
PRIMER3. All primer sequences are available at our
Web site ARVDnet. Each exon was amplified from pa-
tient genomic DNA, purified (PCR Product Presequenc-
ing kit; USB), and sequenced using the BIG DYE di-
deoxy-terminator chemistry (Perkin Elmer) on an ABI
377 DNA sequencer.
DNA sequencing of all DSP exons in the index case
revealed a missense mutation in exon 7, (C1176G;
AGCrAGG). This mutation was detected in all clinically
affected individuals and in some relatives whose clinical
status is still unknown, since they were very recently
recruited to the study. It was detected as well by SSCP
analysis (fig. 3). SSCP analysis was performed under the
following conditions: 5 ml of a 35-cycle PCR mixture
was denatured and separated on a nondenaturing 10%
polyacrylamide gel (29:1 acrylamide:bisacrylamide, 5%
glicerol), in 1# TBE buffer at room temperature. Single-
strand conformations were detected by silver staining.
C1176G mutation could not be detected in any of
240 control subjects (480 alleles) from the same popu-
lation, thus suggesting such nucleotide substitution is
pathogenic.
Ser residue (S299R) mutated in patients was placed
at the center of a coiled, charged region, separating the
two short helices of DSP subdomain Z. Such a coiled
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region is predicted to be a surface region, possibly in-
volved in protein-protein interactions. The S299R amino
acid substitution suppresses a putative phosphorylation
site that is fully conserved in related proteins belonging
to the same family (fig. 4), supporting the hypothesis
that the amino acid change might cause a functional
alteration.
DNA sequencing revealed an additional variant in
exon 7: an ArT transversion resulting in the substitution
of an isoleucin with a phenilalanin residue (I305F). Sub-
sequent analysis revealed that I305F is a relatively com-
mon (∼8% in frequency) polymorphism in the control
population. A single-base insertion before the ATG start
codon of DSP (at position –1), cosegregating with the
disease in the family, was also detected. Because this
insertion does not alter the optimal context of the ini-
tiation codon (Kozak et al. 1984), no pathogenic effect
is expected for such a variant.
DSP, together with JUP, anchors to desmosomal cad-
herins, forming an ordered array of nontransmembrane
proteins, which then bind to keratin intermediate fila-
ments (IF) (Kowalczyk et al. 1997; Smith et al. 1998;
Leung et al. 2002). Desmosomes are major cell-cell junc-
tions, particularly abundant in epidermal cells and in
cardiomyocytes (Gallicano et al. 1998; Smith et al.
1998). DSP consists of 2,871 amino acids, and it is pre-
dicted to be a homodimer containing two globular end
domains joined by a central alpha-helical coiled-coil rod
domain (O’Keefe et al. 1989; Green et al. 1990; Virata
et al. 1992). A carboxy-terminal domain ofDSP interacts
with IF (Stappenbeck et al. 1993; Kouklis et al. 1994;
Meng et al. 1997), whereas amino-terminal domain in-
cluding 2-subdomain is required for DSP localization to
the desmosomal plaque (Stappenbeck et al. 1993) and
is binding to JUP (Kowalczyk et al. 1997).
Mutated Ser residue in the Z subdomain represents
the only PKC phosphorylation site conserved in the
whole N-terminal of all PKC-regulated plakins (data not
shown). Such residue is likely to represent a crucial site
for PKC-mediated regulation of DSP interactions with
desmosomal components at the plasma membrane side.
Moreover, the first 584 amino acids of the N-terminal
domain, where S299R mutation was detected, are
known to be involved in JUP binding and in clustering
of desmosomal cadherin-JUP complexes (Kowalczyk et
al. 1997).
Nonsense DSP mutations, leading to functionally null
alleles, were reported to have produced striate palmo-
plantar keratoderma in heterozygotes, thus demonstrat-
ing that dosage of DSP is critical in maintaining epi-
dermal integrity (Armstrong et al. 1999; Whittock et al.
1999, 2002). Conversely, heterozygotes for DSP trun-
cated at its C-terminal domain (Carvajal syndrome)
showed no keratoderma; it was suggested that, in this
case, either DSP binding to IF is reduced but not lost or
that loss of desmosomes-IF binding via DSP could be
compensated for by other desmosomal proteins (Norgett
et al. 2000).
It is possible that absence of skin defects in hetero-
zygous carriers of DSP missense mutation S299R can be
explained by considering that this mutation does not
affect DSP-IF binding, which, on the contrary, is targeted
by other mutations producing a keratoderma phenotype.
In heterozygotes for the S299R mutation, the majority
of desmosomal cadherin-JUP complexes would be de-
fective because of the dimeric nature of DSP functional
molecules. This would explain the dominant pattern of
inheritance of the disease caused by such mutation.
The involvement of two desmosomal proteins (DSP
and JUP) in two different ARVD/C clinical phenotypes
(ARVD8 and Naxos disease) suggests that some ARVD/
C might result from defects in intercellular connections.
According to present knowledge, mechanical forces ap-
plied to adherens junctions activate stretch-sensitive cal-
cium-permeable channels via cadherins’ mechanical
intracellular signaling (Ko et al. 2001). Moreover,
stretching of cardiomyocytes is known to modulate the
elementary calcium release process from ryanodine re-
ceptor release channels (Petroff et al. 2001). Therefore,
a genetically impaired response to mechanical stress
might adversely affect intracellular calcium concentra-
tion and the excitation-contraction coupling. In addi-
tion, it might induce apoptosis and cellular necrosis,
which, in turn, would promote fibrosis and adipose sub-
stitution, as in several muscular dystrophies. The almost
selective affection of the right ventricle might be in re-
lation to its extensibility, in comparison with that of left-
ventricular free wall. It is interesting to notice that mu-
tations in RYR2 (cardiac ryanodine receptor) cause
dominant ARVD/C type 2, thus supporting the hypo-
thesis of a key pathogenic role played by altered intra-
cellular calcium concentration in these diseases.
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